Compounds > ipriflavone

ipriflavone and hydroxyproline

ipriflavone has been researched along with hydroxyproline in 10 studies

Research

Studies (10)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's10 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Carnevale, V; Mazzuoli, G; Minisola, S; Pacitti, MT; Romagnoli, E; Rosso, R; Scarda, A; Scarnecchia, L1
Agnusdei, D; Baroni, MC; Camporeale, A; Gennari, C; Gonnelli, S; Passeri, M1
Abate, G; Biondi, M; Bufalino, L; Castiglione, GN; Costi, D; Di Peppe, C; Passeri, M1
Cappagli, B; Facchini, V; Gambacciani, M; La Commare, P; Manetti, P; Piaggesi, L; Spinetti, A; Taponeco, F; Teti, GC; Weiss, C1
Notoya, K; Taketomi, S; Tsukuda, R; Yoshida, K1
Adami, S; Bufalino, L; Cervetti, R; Di Marco, C; Di Munno, O; Fantasia, L; Isaia, GC; Passeri, M; Serni, U; Vecchiet, L1
Adami, S; Agnusdei, D; Bufalíno, L; Cervetti, R; Crepaldi, G; Di Marco, C; Di Munno, O; Fantasia, L; Gennari, C; Isaia, GC; Mazzuoli, GF; Ortolani, S; Passeri, M; Serni, U; Vecchiet, L1
Agnusdei, D; Bufalino, L1
Altieri, P; Bottiglioni, F; Ciaponi, M; de Aloysio, D; Gambacciani, M; Genazzani, AR; Mura, M; Ventura, V1
Agnusdei, D; Bufalino, L; Crepaldi, G; Gennari, C; Isaia, G; Mazzuoli, G; Ortolani, S; Passeri, M1

Trials

8 trial(s) available for ipriflavone and hydroxyproline

ArticleYear
Short-term treatment of Paget's disease of bone with ipriflavone.
    Bone and mineral, 1992, Volume: 19 Suppl 1

    Topics: Administration, Oral; Aged; Alkaline Phosphatase; Bone and Bones; Creatinine; Double-Blind Method; Female; Humans; Hydroxyproline; Isoflavones; Male; Middle Aged; Osteitis Deformans; Pain

1992
Effect of ipriflavone on bone mass in elderly osteoporotic women.
    Bone and mineral, 1992, Volume: 19 Suppl 1

    Topics: Aged; Aged, 80 and over; Bone Density; Creatinine; Double-Blind Method; Female; Humans; Hydroxyproline; Isoflavones; Osteocalcin; Osteoporosis; Spinal Fractures

1992
Ipriflavone prevents the bone mass reduction in premenopausal women treated with gonadotropin hormone-releasing hormone agonists.
    Bone and mineral, 1994, Volume: 26, Issue:1

    Topics: Adult; Bone and Bones; Bone Density; Bone Diseases, Metabolic; Dose-Response Relationship, Drug; Double-Blind Method; Drug Interactions; Female; Gonadotropin-Releasing Hormone; Humans; Hydroxyproline; Isoflavones; Middle Aged; Osteocalcin; Premenopause; Time Factors

1994
Ipriflavone prevents radial bone loss in postmenopausal women with low bone mass over 2 years.
    Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, 1997, Volume: 7, Issue:2

    Topics: Aged; Bone and Bones; Bone Density; Female; Humans; Hydroxyproline; Isoflavones; Middle Aged; Osteoporosis, Postmenopausal; Radius

1997
Effect of chronic treatment with ipriflavone in postmenopausal women with low bone mass.
    Calcified tissue international, 1997, Volume: 61 Suppl 1

    Topics: Absorptiometry, Photon; Administration, Oral; Aged; Analysis of Variance; Biomarkers; Bone Density; Bone Remodeling; Cohort Studies; Creatinine; Double-Blind Method; Female; Humans; Hydroxyproline; Isoflavones; Lumbar Vertebrae; Middle Aged; Osteocalcin; Osteoporosis, Postmenopausal; Radius

1997
Efficacy of ipriflavone in established osteoporosis and long-term safety.
    Calcified tissue international, 1997, Volume: 61 Suppl 1

    Topics: Absorptiometry, Photon; Administration, Oral; Aged; Analysis of Variance; Bone Density; Bone Remodeling; Calcitriol; Calcium, Dietary; Double-Blind Method; Female; Humans; Hydroxyproline; Incidence; Isoflavones; Italy; Osteoporosis, Postmenopausal; Prevalence; Spinal Fractures

1997
Bone density changes in postmenopausal women with the administration of ipriflavone alone or in association with low-dose ERT.
    Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 1997, Volume: 11, Issue:4

    Topics: Administration, Cutaneous; Alkaline Phosphatase; Body Mass Index; Bone Density; Bone Remodeling; Creatinine; Estradiol; Estrogen Replacement Therapy; Female; Humans; Hydroxyproline; Isoflavones; Postmenopause

1997
Effect of ipriflavone--a synthetic derivative of natural isoflavones--on bone mass loss in the early years after menopause.
    Menopause (New York, N.Y.), 1998,Spring, Volume: 5, Issue:1

    Topics: Administration, Oral; Alkaline Phosphatase; Biomarkers; Bone Density; Calcium; Cohort Studies; Creatinine; Female; Humans; Hydroxyproline; Isoflavones; Middle Aged; Osteocalcin; Osteoporosis, Postmenopausal; Spine

1998

Other Studies

2 other study(ies) available for ipriflavone and hydroxyproline

ArticleYear
Effects of ipriflavone on bone remodeling in primary hyperparathyroidism.
    Bone and mineral, 1992, Volume: 19 Suppl 1

    Topics: Adult; Aged; Bone Remodeling; Calcium; Creatinine; Female; Humans; Hydroxyproline; Hyperparathyroidism; Isoflavones; Male; Middle Aged; Osteocalcin; Phosphorus

1992
Effect of ipriflavone on expression of markers characteristic of the osteoblast phenotype in rat bone marrow stromal cell culture.
    Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research, 1994, Volume: 9, Issue:3

    Topics: Alkaline Phosphatase; Animals; Bone Development; Bone Marrow; Bone Marrow Cells; Calcification, Physiologic; Cell Differentiation; Cell Division; Cells, Cultured; Dexamethasone; Femur; Glycerophosphates; Hydroxyproline; Isoflavones; Osteoblasts; Osteocalcin; Phenotype; Rats; Stromal Cells

1994